PPG2ABP: Translating Photoplethysmogram (PPG) Signals to Arterial Blood Pressure (ABP) Waveforms

Author:

Ibtehaz Nabil,Mahmud SakibORCID,Chowdhury Muhammad E. H.ORCID,Khandakar AmithORCID,Salman Khan MuhammadORCID,Ayari Mohamed ArseleneORCID,Tahir Anas M.,Rahman M. SohelORCID

Abstract

Cardiovascular diseases are one of the most severe causes of mortality, annually taking a heavy toll on lives worldwide. Continuous monitoring of blood pressure seems to be the most viable option, but this demands an invasive process, introducing several layers of complexities and reliability concerns due to non-invasive techniques not being accurate. This motivates us to develop a method to estimate the continuous arterial blood pressure (ABP) waveform through a non-invasive approach using Photoplethysmogram (PPG) signals. We explore the advantage of deep learning, as it would free us from sticking to ideally shaped PPG signals only by making handcrafted feature computation irrelevant, which is a shortcoming of the existing approaches. Thus, we present PPG2ABP, a two-stage cascaded deep learning-based method that manages to estimate the continuous ABP waveform from the input PPG signal with a mean absolute error of 4.604 mmHg, preserving the shape, magnitude, and phase in unison. However, the more astounding success of PPG2ABP turns out to be that the computed values of Diastolic Blood Pressure (DBP), Mean Arterial Pressure (MAP), and Systolic Blood Pressure (SBP) from the estimated ABP waveform outperform the existing works under several metrics (mean absolute error of 3.449 ± 6.147 mmHg, 2.310 ± 4.437 mmHg, and 5.727 ± 9.162 mmHg, respectively), despite that PPG2ABP is not explicitly trained to do so. Notably, both for DBP and MAP, we achieve Grade A in the BHS (British Hypertension Society) Standard and satisfy the AAMI (Association for the Advancement of Medical Instrumentation) standard.

Funder

Qatar National Research Fund

Qatar University

Publisher

MDPI AG

Subject

Bioengineering

Reference78 articles.

1. Heart regeneration;Nature,2011

2. Cardiovascular disease in Europe: Epidemiological update 2016;Eur. Heart J.,2016

3. (2022, October 22). Vital Signs: Awareness and Treatment of Uncontrolled Hypertension Among Adults—The United States, 2003–2010. Centers for Disease Control and Prevention, 7 September 2012, Available online: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6135a3.htm.

4. A Global Brief on Hypertension: Silent Killer, Global Public Health Crisis: World Health Day 2013 (2022, October 22). World Health Organization. Available online: https://www.who.int/publications/i/item/a-global-brief-on-hypertension-silent-killer-global-public-health-crisis-world-health-day-2013.

5. Symplicity HTN-1 Investigators (2011). Catheter-based renal sympathetic denervation for resistant hypertension: Durability of blood pressure reduction out to 24 months. Hypertension, 57, 911–917.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3